🤖Artificial Intelligence in Cardiovascular Care @JACC Review Topic of the Week 👉Applications of artificial intelligence (AI) to CV care have accelerated as a result of advances in multimodal inputs and generative technology 👉Realizing the potential of AI requires enhanced

Want to know the state of AI & Cardiology? Our #JACC reviews are for you! bit.ly/3J5yj4W Pt 1: The field's most comprehensive primer. Every study you should know about in 1 place Pt 2: Tackling today's evidence, equity, & regulatory challenges Eric Topol Matthew Lungren MD MPH

One of the most important #RCT results in #ACC2024. Probably same is the case for some other domains such as antithrombotic therapy, heart failure, and others. Data #age ⌛️ matters. RCTs have an #expiration date when co-treatments or pt populations change. Harlan Krumholz

Per ADA guidelines, regardless of A1c, people with type 2 diabetes with high risk factors for or established ASCVD should be considered for SGLT-2 inhibitor/GLP-1 agonist therapy. Same goes for CKD & albuminuria on max tolerated ACEI/ARB. These are cardiometabolic meds!

You never know who you will run into at SFO! Wonderful to catch up with you David J. Cohen, MD, MSc.

Excited to share our #echofirst foundation model is now published in Nature Medicine! Trained on 1M Cedars-Sinai A4C echo-report pairs, EchoCLIP has strong performance on wide range of cardiac diagnostic benchmarks, including LVEF in Stanford Medicine videos (MAE 7.1%).

Congrats to my entering class on graduating cardiology fellowship StanfordCVFellowship! I am lucky to have been blessed with such a group of talented doctors to be my co-fellows and excited to see how you all will shape the future! David E Wang, MD Zaniar Ghazizadeh Yaanik Desai Sneha Shah Jain, MD, MBA

Realizing AI's potential in cardiology requires rigorous evaluation, appropriate infrastructure, regulatory oversight, ethics and equity analyses, and viable business cases for deployment. bit.ly/3VnoaGu #JACC #AI #ArtificialIntelligence #HealthEquity Sneha Shah Jain, MD, MBA

Prospective RCT of AI-Enhanced ECG for STEMI Activation NEJM AI ai.nejm.org/doi/full/10.10… Excellent trial building upon and complementing recent work in Nature Medicine nature.com/articles/s4159… Excellent editorial by Robert Avram and William Fearon ai.nejm.org/doi/full/10.10…

We are thrilled to announce our new Chair of the Stanford Department of Medicine, Dr. Euan Ashley euan ashley . We have a great future ahead!!! Dr. Ashley becomes Chair Sept 18th, 2024.

Dr. Sneha Shah Jain, MD, MBA addresses the responsible and effective deployment of #AI in CV care: “It’s essential to evaluate both intended and unintended consequences.” bit.ly/4d2rIF8 #ACCInnovation #TransformCVCare

Hager et al. assessed LLM performance in clinical decision-making (nature.com/articles/s4159…). In Nature Medicine, Suhana Bedi, Nigam Shah, and I discuss the main takeaways from this excellent paper and share a framework for evaluating LLMs for clinical use (nature.com/articles/s4159…)

Looking forward to your talk, Leandro! Leandro Slipczuk

Ron Blankstein presents at joint Heart_SCCT ASPC session #ASPC2024 🫀CAC is in our chest pain guidelines 🫀 CAD is more than obstructive CAD 🫀CCTA was the only class IA imaging rec 🫀Tx should start with any CAD!

⁦Leandro Slipczuk⁩ on exciting future of coronary CTA - from Radiomics to #AI . Tx of non obstructive CAD prevent 💔 events! #ASPC2024 ⁦Michael D. Shapiro⁩ ⁦Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦⁩

Fantastic job, Sarkis!!